13D Filing: Starboard Value Reports Stake and Goes Activist on Depomed Inc (DEPO)

Page 17 of 35

Page 17 of 35 – SEC Filing

The following constitutes the Schedule 13D filed by the undersigned (the “Schedule 13D”).
Item 1.
Security and Issuer.
This statement relates to the common stock, no par value (the “Shares”), of Depomed, Inc., a California corporation (the “Issuer”).  The address of the principal executive offices of the Issuer is 7999 Gateway Boulevard, Suite 300, Newark, California 94560.
Item 2.
Identity and Background.
(a)           This statement is filed by:
 
(i)
Starboard Value and Opportunity Master Fund Ltd, a Cayman Islands exempted company (“Starboard V&O Fund”), with respect to the Shares directly and beneficially owned by it;
 
(ii)
Starboard Value and Opportunity S LLC, a Delaware limited liability company (“Starboard S LLC”), with respect to the Shares directly and beneficially owned by it;
 
(iii)
Starboard Value and Opportunity C LP, a Delaware limited partnership (“Starboard C LP”), with respect to the Shares directly and beneficially owned by it;
 
(iv)
Starboard Value R LP (“Starboard R LP”), as the general partner of Starboard C LP;
 
(v)
Starboard Value R GP LLC (“Starboard R GP”), as the general partner of Starboard R LP;
 
(vi)
Starboard Value LP (“Starboard Value LP”), as the investment manager of Starboard V&O Fund, Starboard C LP and of a certain managed account (the “Starboard Value LP Account”) and the manager of Starboard S LLC;
 
(vii)
Starboard Value GP LLC (“Starboard Value GP”), as the general partner of Starboard Value LP;
 
(viii)
Starboard Principal Co LP (“Principal Co”), as a member of Starboard Value GP;
 
(ix)
Starboard Principal Co GP LLC (“Principal GP”), as the general partner of Principal Co;
 
(x)
Jeffrey C. Smith, as a member of Principal GP and as a member of each of the Management Committee of Starboard Value GP and the Management Committee of Principal GP and as a nominee for the Board of Directors of the Issuer (the “Board”);

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Page 17 of 35